Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 44.00 | |
5 mg | In stock | $ 98.00 | |
10 mg | In stock | $ 148.00 | |
25 mg | In stock | $ 293.00 | |
50 mg | In stock | $ 437.00 | |
100 mg | In stock | $ 646.00 |
Description | ABT530 (Pibrentasvir) is an HCV NS5A inhibitor with EC50s ranging from 1.4-5.0 pM against HCV replicons containing NS5A from genotypes 1-6. |
Targets&IC50 | HCV NS5A:1.4-5.0 pM(EC50) |
Synonyms | ABT 530, ABT-530, Pibrentasvir |
Molecular Weight | 1113.18 |
Formula | C57H65F5N10O8 |
CAS No. | 1353900-92-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (44.92 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT530 1353900-92-1 Microbiology/Virology Proteases/Proteasome HCV Protease ABT 530 ABT-530 Pibrentasvir inhibitor inhibit